Additionally, some investigations have also explored the relationship between IFI30 and cancer, revealing that IFI30 expression exhibits a robust relationship with immune cell infiltration and the prognosis of prostate cancer, melanoma, breast cancer, and glioma [15–18]. Here, IFI30 is linked to prostate carcinoma.